<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134549">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01350102</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-35832</org_study_id>
    <nct_id>NCT01350102</nct_id>
  </id_info>
  <brief_title>The Relationship of Hemoglobin A1c and Diabetic Wound Healing</brief_title>
  <official_title>The Relationship of Hemoglobin A1c and Diabetic Wound Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Susan Hassenbein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic
      wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health
      Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will
      be done to evaluate impact on time to wound closure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized controlled study evaluating the relationship of hemoglobin
      A1c in diabetic wound healing. Length of time for wound closure will be compared using four
      treatment options.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    study closed due to recruitment problems
  </why_stopped>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound healing</measure>
    <time_frame>Patients are assessed every other week (bi-weekly) until 100% wound healing is achieved, which may take up to 6 months</time_frame>
    <description>Assessment of wound healing will be assessed on a biweekly basis. Healing will be defined as 100% wound re-epithelialization or wound closure. Wounds will be measured in regard to width and depth, digital images taken, and the wound assessed according to standard wound descriptors at each visit until 100% wound healing. The wound will also be given a Wagner classification. Patients will record dressing application, non-weight bearing status, and vitamin C consumption. Hgb A1c and vitamin C levels will be drawn at enrollment and at three month intervals. Wound healing may take up to 6 months.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Diabetes, Type 1</condition>
  <condition>Diabetes, Type 2</condition>
  <condition>Foot Ulcer, Diabetic</condition>
  <arm_group>
    <arm_group_label>Bacitracin wound care dressing alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bacitracin wound care dressing alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bacitracin with Vit C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bacitracin wound care dressing with Vitamin C supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AmeriGel® wound care dressing alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AmeriGel® wound care dressing alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AmeriGel® with Vit C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AmeriGel® wound care dressing with Vitamin C supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bacitracin</intervention_name>
    <description>Participants will be treated with Bacitracin to their wound until 100% wound healing, which may take up to 6 months to achieve.</description>
    <arm_group_label>Bacitracin wound care dressing alone</arm_group_label>
    <arm_group_label>Bacitracin with Vit C</arm_group_label>
    <other_name>Baciguent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AmeriGel®</intervention_name>
    <description>Participants will be treated with AmeriGel® to their wound until 100% wound healing, which may take up to 6 months to achieve.</description>
    <arm_group_label>AmeriGel® wound care dressing alone</arm_group_label>
    <arm_group_label>AmeriGel® with Vit C</arm_group_label>
    <other_name>Oakin®-based hydrogel</other_name>
    <other_name>hydrogel containing Oakin®</other_name>
    <other_name>Oak extract</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hemoglobin A1c</intervention_name>
    <description>Hemoglobin A1c levels will be performed and reviewed every three months to assess its relationship to wound healing</description>
    <arm_group_label>Bacitracin wound care dressing alone</arm_group_label>
    <arm_group_label>Bacitracin with Vit C</arm_group_label>
    <arm_group_label>AmeriGel® wound care dressing alone</arm_group_label>
    <arm_group_label>AmeriGel® with Vit C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin C</intervention_name>
    <description>Participants will be treated with Vitamin C supplements 1000 mg daily until 100% wound healing, which may take up to 6 months to achieve</description>
    <arm_group_label>Bacitracin with Vit C</arm_group_label>
    <arm_group_label>AmeriGel® with Vit C</arm_group_label>
    <other_name>ascorbic acid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years of age

          -  Diabetic (Type I and Type II)

          -  Ulceration of the foot at least one centimeter in width/length

          -  Ulceration at least 0.2 centimeters in depth

        Exclusion Criteria:

          -  Ulceration width/length &gt; 7.5 centimeters

          -  Wound depth &gt; 1.25 centimeters

          -  Purulent, excessive drainage and/or other signs of infection (i.e. erythema, edema,
             warmth)

          -  Inability to provide informed consent

          -  Inability to swallow pills (vitamin C supplement)

          -  Patients with concurrent renal problems

          -  Patients with medication contraindications to Vitamin C and/or topical wound
             dressings
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nell V. Blake, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Markuson M, Hanson D, Anderson J, Langemo D, Hunter S, Thompson P, Paulson R, Rustvang D. The relationship between hemoglobin A(1c) values and healing time for lower extremity ulcers in individuals with diabetes. Adv Skin Wound Care. 2009 Aug;22(8):365-72. doi: 10.1097/01.ASW.0000358639.45784.cd.</citation>
    <PMID>19638800</PMID>
  </reference>
  <reference>
    <citation>Jensen JL, Seeley J, Gillin B. Diabetic foot ulcerations. A controlled, randomized comparison of two moist wound healing protocols: Carrasyn Hydrogel Wound dressing and wet-to-moist saline gauze. Adv Wound Care. 1998 Nov-Dec;11(7 Suppl):1-4.</citation>
    <PMID>10326334</PMID>
  </reference>
  <reference>
    <citation>Storm DR. Mechanism of bacitracin action: a specific lipid-peptide interaction. Ann N Y Acad Sci. 1974 May 10;235(0):387-98.</citation>
    <PMID>4368896</PMID>
  </reference>
  <reference>
    <citation>Falabella A, Falanga V. Uncommon causes of ulcers. Clin Plast Surg. 1998 Jul;25(3):467-79. Review.</citation>
    <PMID>9696906</PMID>
  </reference>
  <reference>
    <citation>Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994 Apr;130(4):489-93. Review.</citation>
    <PMID>8166487</PMID>
  </reference>
  <reference>
    <citation>Maklebust JA, Margolis D. The goodness of measurement. Adv Wound Care. 1996 May-Jun;9(3):6.</citation>
    <PMID>8716267</PMID>
  </reference>
  <reference>
    <citation>van Rijuswijl L. Wound assessment and documentation. In: Krasner LD, Rodeheaver GT, Sibbald RG (eds). Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, 3rd ed. Wayne Pa: HMP Communications: 2001;101-115.</citation>
  </reference>
  <reference>
    <citation>Keast DH, Bowering CK, Evans AW, Mackean GL, Burrows C, D'Souza L. MEASURE: A proposed assessment framework for developing best practice recommendations for wound assessment. Wound Repair Regen. 2004 May-Jun;12(3 Suppl):S1-17. Review.</citation>
    <PMID>15230830</PMID>
  </reference>
  <reference>
    <citation>Haslik W, Kamolz LP, Andel H, Winter W, Meissl G, Frey M. The influence of dressings and ointments on the qualitative and quantitative evaluation of burn wounds by ICG video-angiography: an experimental setup. Burns. 2004 May;30(3):232-5.</citation>
    <PMID>15082349</PMID>
  </reference>
  <reference>
    <citation>Droog EJ, Steenbergen W, Sjöberg F. Measurement of depth of burns by laser Doppler perfusion imaging. Burns. 2001 Sep;27(6):561-8.</citation>
    <PMID>11525849</PMID>
  </reference>
  <reference>
    <citation>Duckworth WC, Fawcett J, Reddy S, Page JC. Insulin-degrading activity in wound fluid. J Clin Endocrinol Metab. 2004 Feb;89(2):847-51.</citation>
    <PMID>14764804</PMID>
  </reference>
  <reference>
    <citation>Zimny S, Schatz H, Pfohl M. Determinants and estimation of healing times in diabetic foot ulcers. J Diabetes Complications. 2002 Sep-Oct;16(5):327-32.</citation>
    <PMID>12200075</PMID>
  </reference>
  <reference>
    <citation>Rubinstein A, Pierce CE Jr. Rapid healing of diabetic foot ulcers with meticulous blood glucose control. Acta Diabetol Lat. 1988 Jan-Mar;25(1):25-32.</citation>
    <PMID>3043987</PMID>
  </reference>
  <reference>
    <citation>Yue DK, McLennan S, Marsh M, Mai YW, Spaliviero J, Delbridge L, Reeve T, Turtle JR. Effects of experimental diabetes, uremia, and malnutrition on wound healing. Diabetes. 1987 Mar;36(3):295-9.</citation>
    <PMID>3803737</PMID>
  </reference>
  <reference>
    <citation>Vitamin C and the common cold. Med Lett Drugs Ther. 1970 Dec 25;12(26):105-6.</citation>
    <PMID>4936077</PMID>
  </reference>
  <reference>
    <citation>Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, Lubin F, Marubini E, Modan B, Rohan T, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990 Apr 4;82(7):561-9.</citation>
    <PMID>2156081</PMID>
  </reference>
  <reference>
    <citation>Wassertheil-Smoller S, Romney SL, Wylie-Rosett J, Slagle S, Miller G, Lucido D, Duttagupta C, Palan PR. Dietary vitamin C and uterine cervical dysplasia. Am J Epidemiol. 1981 Nov;114(5):714-24.</citation>
    <PMID>7304600</PMID>
  </reference>
  <reference>
    <citation>Snyder RJ, Kirsner RS, Warriner RA 3rd, Lavery LA, Hanft JR, Sheehan P. Consensus recommendations on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. Ostomy Wound Manage. 2010 Apr;56(4 Suppl):S1-24.</citation>
    <PMID>20424290</PMID>
  </reference>
  <reference>
    <citation>Pollack SV. Wound healing: a review. III. Nutritional factors affecting wound healing. J Dermatol Surg Oncol. 1979 Aug;5(8):615-9.</citation>
    <PMID>479447</PMID>
  </reference>
  <reference>
    <citation>van Anholt RD, Sobotka L, Meijer EP, Heyman H, Groen HW, Topinková E, van Leen M, Schols JM. Specific nutritional support accelerates pressure ulcer healing and reduces wound care intensity in non-malnourished patients. Nutrition. 2010 Sep;26(9):867-72. doi: 10.1016/j.nut.2010.05.009. Epub 2010 Jul 3.</citation>
    <PMID>20598855</PMID>
  </reference>
  <reference>
    <citation>Smith RG. Validation of Wagner's classification: a literature review. Ostomy Wound Manage. 2003 Jan;49(1):54-62. Review.</citation>
    <PMID>12532034</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <lastchanged_date>May 6, 2015</lastchanged_date>
  <firstreceived_date>May 4, 2011</firstreceived_date>
  <firstreceived_results_disposition_date>April 14, 2015</firstreceived_results_disposition_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Penn State Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Susan Hassenbein</investigator_full_name>
    <investigator_title>Clinical Research Associate</investigator_title>
  </responsible_party>
  <keyword>Adult</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Bacitracin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted -->
</clinical_study>
